Norway, July 8 -- EXACT Therapeutics AS, a clinical stage precision medicine company utilizing the power of ultrasound to enable targeted drug delivery in oncology, has been informed that the United States Patent and Trademark Office (USPTO) has granted EXACT its U.S. Patent No. 12,343,396 entitled "Ultrasound mediated delivery of drugs".The granted patent covers the treatment of patients with a pharmaceutical using EXACT's proprietary agent PS101 and Acoustic Cluster Therapy (ACT(R)).
Published by HT Digital Content Services with permission from Pivotal Sources....